Is ciclopirox used to treat psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ciclopirox is NOT Used for Psoriasis

Ciclopirox is a topical antifungal agent with no established role in psoriasis treatment. The evidence provided discusses cyclosporine (also spelled ciclosporin), which is an entirely different medication—an immunosuppressive agent approved for severe psoriasis 1.

Critical Distinction Between Two Different Medications

  • Ciclopirox is a hydroxypyridone antifungal agent used for dermatophyte infections, onychomycosis, seborrheic dermatitis, and vaginal candidiasis 2
  • Cyclosporine/Ciclosporin is a calcineurin inhibitor immunosuppressant used for severe psoriasis and atopic dermatitis 1, 3

These are completely unrelated drugs with different mechanisms, indications, and chemical structures 2, 4.

Why Ciclopirox Has No Role in Psoriasis

  • Ciclopirox works by chelating trivalent metal cations to inhibit metal-dependent enzymes in fungal cells, making it purely antimicrobial 2
  • While ciclopirox demonstrates mild anti-inflammatory effects through scavenging reactive oxygen species, these effects are minimal and have only been shown in small biochemical studies—not in psoriasis treatment 2
  • Psoriasis is an autoimmune T-cell mediated disease requiring immunosuppression or immunomodulation, not antifungal therapy 4

Common Pitfall to Avoid

The similar spelling of "ciclopirox" and "ciclosporin" creates confusion, but prescribing ciclopirox for psoriasis would be a medication error. If you intended to ask about cyclosporine for psoriasis, that is a well-established treatment with strong evidence 1, 3, 5.

What IS Used for Psoriasis

If seeking systemic therapy for severe psoriasis, the British Association of Dermatologists recommends cyclosporine (not ciclopirox) at 2.5-5 mg/kg/day, achieving 50-70% PASI 75 response within 8-16 weeks 1, 5. However, this requires careful monitoring for nephrotoxicity and hypertension 1, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cyclosporine Use in Dermatology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The use of ciclosporin in psoriasis.

The Journal of dermatological treatment, 2005

Guideline

Cyclosporine Therapy for Chronic Plaque Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Blood Pressure Monitoring for Cyclosporine in Psoriasis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.